LXEO Lexeo Therapeutics PE ratio, current and historical analysis

As of Mar 19, 2025, the Lexeo Therapeutics stock's PE ratio is 0.17. This results from the current EPS of $17.54 and stock price of $3.04.

LXEO PE ratio history

How has LXEO's PE ratio performed in the past
Today
0.16
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Lexeo Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2023 N/A N/A $13.42 -$12.4
2022 N/A N/A N/A -$36.36
2021 N/A N/A N/A -$32.6

Lexeo Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Sep 2024 0.52 -80.3% $9.04 $17.54
Jun 2024 2.64 N/A $16.04 $6.07
Mar 2024 N/A N/A $15.68 -$1.59
Dec 2023 N/A N/A $13.42 -$12.4
Sep 2023 N/A N/A N/A -$41.1
Jun 2023 N/A N/A N/A -$39.12
Mar 2023 N/A N/A N/A -$40.05
Dec 2022 N/A N/A N/A -$36.36
Sep 2022 N/A N/A N/A N/A
Jun 2022 N/A N/A N/A N/A
Dec 2021 N/A N/A N/A -$32.6

LXEO average PE ratio chart

What is the average PE ratio of LXEO for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

LXEO PE vs peers

What is LXEO's PE ratio compared to its peers
Stock name PE ratio Market cap
LXEO Lexeo Therapeutics Inc. 0.16 $91.26M
NTLA Intellia Therapeutics Inc N/A $909.92M
BLUE bluebird bio Inc N/A $37.04M
CRSP CRISPR Therapeutics AG N/A $3.55B
EDIT Editas Medicine Inc N/A $112.02M
QURE uniQure NV N/A $740.85M
RGNX REGENXBIO Inc N/A $410.46M
SGMO Sangamo Therapeutics Inc N/A $189.9M
ADVM Adverum Biotechnologies Inc N/A $116.7M
BEAM Beam Therapeutics Inc N/A $1.92B
VERV Verve Therapeutics Inc N/A $481.27M

Frequently asked questions

What is Lexeo Therapeutics's PE ratio?

As of Mar 19, 2025, LXEO stock has a price to earnings ratio of 0.17.

Why is Lexeo Therapeutics's PE ratio so low?

LXEO's stock price is trading at a lower multiple of earnings, which is why its PE ratio of 0.17 is considered low.

How is LXEO's PE ratio calculated (Lexeo Therapeutics PE ratio formula)?

You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Mar 19, 2025), Lexeo Therapeutics's stock price is $3.04. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $17.54. Therefore, Lexeo Therapeutics's P/E ratio for today is 0.17. PE RATIO(0.17) = STOCK PRICE($3.04) / TTM EPS($17.54)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.